Home / Medicine / The ASAM Essentials of Addiction Medicine

The ASAM Essentials of Addiction Medicine

The ASAM Essentials of Addiction Medicine

9781451194463
ISBN/ISSN
9781451194463
Publication Date
May 8, 2015
2015-05-8
Availability
IN STOCK
9781451194463
Preview link
Rights Link
$ 92.99 USD $92.99
*Final price may vary based on conversion rate.
Quantity
System.String
""
Item already added to cart.

Share

Sorry! Promocode will not apply for this product.

  • Description
    Publisher’s Note:   Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product.

    A masterful, high-yield guide to the treatment of substance abuse issues, The ASAM Essentials of Addiction Medicine equips you with the expert know-how you need to provide effective help for your patients. Derived from The ASAM Principles of Addiction Medicine, 5th Edition – widely hailed as the definitive comprehensive clinical reference in the field – this companion resource presents the collective wisdom of hundreds of esteemed authorities on the art and science of addition medicine. Yet, it does so in a succinct format that will appeal to specialists seeking a more streamlined, quick-access reference source.
    • Find the authoritative answers you need on everything from the pharmacology of addiction through diagnosis, assessment, and early intervention; various forms of addiction management…treatment of individual patient populations; management of intoxication and withdrawal; pharmacologic and behavioral interventions; recovery programs; medical disorders and complications…co-occurring addiction and psychiatric disorders; pain and addiction; children and adolescents; and ethical, legal, and liability issues.
    • Contribute to public health in the area of addiction thanks to a special introductory chapter entitled “A Public Health Approach to Prevention: The Health Professional’s Role.”
    • Easily switch back and forth between the ASAMEssentials and the parent text thanks to a parallel chapter organization.
    • Zero in on the most important, practical information thanks to highly focused, efficient coverage.
    • Maximize your understanding and retention of vital concepts with the aid of key points summaries, review questions, and suggested readings in each chapter.
    Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to:
    • Complete content with enhanced navigation
    • A powerful search that pulls results from content in the book, your notes, and even the web
    • Cross-linked pages, references, and more for easy navigation
    • Highlighting tool for easier reference of key content throughout the text
    • Ability to take and share notes with friends and colleagues
    • Quick reference tabbing to save your favorite content for future use
  • Specs
    Edition
    2
    ISBN/ISSN
    9781451194463
    Product Format
    PB-Paperback
    Trim Size
    7 x 10
    Pages
    712
    Illustration
    17
    Table
    100
    Publication Date
    May 8, 2015
    Weight
    2.55
  • About The Author(s)
    Abigail Herron
    Timothy Koehler Brennan MD, MPH
  • Features
    • Find the authoritative answers you need on everything from the pharmacology of addiction through diagnosis, assessment, and early intervention; various forms of addiction management…treatment of individual patient populations; management of intoxication and withdrawal; pharmacologic and behavioral interventions; recovery programs; medical disorders and complications…co-occurring addiction and psychiatric disorders; pain and addiction; children and adolescents; and ethical, legal, and liability issues.
    • Contribute to public health in the area of addiction thanks to a special introductory chapter entitled “A Public Health Approach to Prevention: The Health Professional’s Role.”
    • Easily switch back and forth between the ASAM Essentials and the parent text thanks to a parallel chapter organization.
    • Zero in on the most important, practical information thanks to highly focused, efficient coverage.
    • Maximize your understanding and retention of vital concepts with the aid of key points summaries, review questions, and suggested readings in each chapter.
    Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to:
    • Complete content with enhanced navigation
    • powerful search that pulls results from content in the book, your notes, and even the web
    • Cross-linked pages, references, and more for easy navigation
    • Highlighting tool for easier reference of key content throughout the text
    • Ability to take and share notes with friends and colleagues
    • Quick reference tabbing to save your favorite content for future use

  • Table of contents
    Contributors
    Editors of The ASAM Principles of Addiction Medicine
    Preface
    A Note about Terminology
    Acknowledgments
    Introduction: A Public Health Approach to  Prevention: The Health Professional’s Role
                Linda Richter, PhD, Kevin Kunz, MD, MPH, and Susan E. Foster, MSW
     
    SECTION 1 BASIC SCIENCE AND CORE CONCEPTS
    1 Drug Addiction: The Neurobiology of Behavior Gone Awry
    Nora D. Volkow, MD and Ruben Baler
    2 The Epidemiology of Substance Use Disorders
    Faye Chao, MD
    3 The Anatomy of Addiction
    Thomas J.R. Beveridge, PhD
    4 From Neurobiology to Treatment: Progress Against Addiction
    Eric J. Nestler, MD, PhD
    5 Understanding “Behavioral Addictions”: Insights from Research
    Yvonne H.C. Yau, MSc, Sarah W. Yip, MSc, PhD, and Marc N. Potenza, MD, PhD
     
    SECTION 2 PHARMACOLOGY
    6 Pharmacokinetic and Pharmacodynamic Principles
    Anne Zajicek, MD, PharmD, FAAP and Lori D. Karan, MD, FACP, FASAM
    7 The Pharmacology of Alcohol
    John J. Woodward, BS, MS, PhD
    8 The Pharmacology of Nonalcohol Sedative Hypnotics
    Reshmi Pal, MD, MPH and Gantt P. Galloway, PharmD
    SIDEBAR: GHB
    Reshmi Pal, MD, MPH, John Mendelson, MD, and Gantt P. Galloway, PharmD
    9 The Pharmacology of Opioids
    Eduardo R. Butelman, PhD, Elizabeth Ducat, ANP, Brenda M. Ray, MS, MPH, FNP-BC, and Mary Jeanne Kreek, MD
    10 The Pharmacology of Cocaine, Amphetamines, and Other Stimulants
    David A. Gorelick, MD, PhD and Michael H. Baumann, PhD
    SIDEBAR: Psychoactive “Bath Salts”: A New Class of Designer Stimulants
    Michael H. Baumann, PhD and Kurt R. Lehner, BS
    11 The Pharmacology of Caffeine
    Laura M. Juliano, PhD, Sergi Ferré, MD, PhD, and Roland R. Griffiths, PhD
    12 The Pharmacology of Nicotine and Tobacco
    Coreen B. Domingo, DrPH and Thomas R. Kosten, MD, PhD
    13 The Pharmacology of Marijuana
    Sandra P. Welch, PhD and Robert Malcolm, MD
    14 The Pharmacology of Hallucinogens
    Torsten Passie, MD, MA and John H. Halpern, MD
    15 The Pharmacology of Dissociatives
    Edward F. Domino, MS, MD and Shannon C. Miller, MD, FASAM, DFAPA
    16 The Pharmacology of Inhalants
    Robert L. Balster, PhD
    SIDEBAR: Inhalant Abuse in the Military
    Robert L. Balster, PhD
    17 The Pharmacology of Anabolic–Androgenic Steroids
    David Lehman, MD, MS
    SIDEBAR: Accessing Information on Newly Emerging Drugs of Abuse
    David Lehman, MD, MS
     
    SECTION 3 DIAGNOSIS, ASSESSMENT, AND EARLY INTERVENTION
    18 Screening and Brief Intervention
    Iliya P. Amaza, MD, MPH, Aleksandra Zgierska, MD, PhD and Michael F. Fleming, MD, MPH
    SIDEBAR: Screening and Brief Intervention for Pregnant Women
    Nicolas Bertholet, MD, MSc
    SIDEBAR: Trauma Centers, Hospitals, and Emergency Departments
    Richard D. Blondell, MD
    SIDEBAR: Implementation of Screening and Brief Intervention in Clinical Settings Using Quality Improvement Principles
    Katharine A. Bradley, MD, MPH and Emily C. Williams, PhD, MPH
    SIDEBAR: Screening for Unhealthy Alcohol Use in the Elderly
    James W. Campbell, MD, MS
    19 Laboratory Diagnosis
    Elizabeth A. Warner, MD
    20 Assessment
    Launette Rieb, MD, MSc, CCFP, FCFP
    21 Environmental Approaches to Prevention: A Community-Based Perspective
    Paul J. Gruenewald, PhD, Andrew J. Treno, PhD, Joel W. Grube, AB, MS, PhD, Robert F. Saltz, PhD, and Mallie J. Paschall, PhD
     
    SECTION 4 OVERVIEW OF ADDICTION TREATMENT
    22 Addiction Medicine in America: Its Birth and Early History (1750–1935) with a Modern Postscript
    William L. White, MA and James F. Callahan, DPA
    23 Treatment of Heavy Drinking and Alcohol Use Disorder
    Mark L. Willenbring, MD
    24 The Treatment of Drug Addiction: An Overview
    Andrea G. Barthwell, MD, FASAM and Lawrence S. Brown Jr., MD, MPH, FASAM
    25 Moving Toward Integrated Care for Substance Use Disorders: Lessons from History and the Rest of Health Care
    A. Thomas McLellan, PhD
    26 Effects of Treatment Setting, Duration, and Amount on Patient Outcomes
    John W. Finney, PhD, Rudolf H. Moos, PhD, and Paula L. Wilbourne, PhD
    27 The ASAM Criteria and Matching Patients to Treatment
    David Mee-Lee, MD and Gerald D. Shulman, MA, MAC, FACATA
    28 Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems
    Andrew O’Hagan, MD
    29 Alternative Therapies for Alcohol and Drug Addiction
    David Y-W Lee, PhD
    30 The Harm Reduction Approach to Prevention and Treatment
    Nayla Hariz, MD and Atika Zubera, MD
    SIDEBAR: A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
    Joe Ruggiero, PhD
    31 Quality Improvement for Addiction Treatment
    James H. Ford II, PhD, Kim A. Hoffman, PhD, and Kimberly Johnson, MBA
    32 Nursing Roles in Addressing Addiction
    Marianne T. Marcus, EdD, RN, FAAN, Christine Savage, PhD, RN, CARN, FAAN, and Deborah S. Finnell, DNS, PHMHNP-BC, CARN-AP, FAAN
    33 International Perspectives on Addiction Management
    Nady el-Guebaly, MD, DPsych, DPH, FRCPC, DABAM, Vladimir Poznyak, MD, PhD, and Juana M. Tomás-Rosselló, MD, MPH
     
    SECTION 5 SPECIAL ISSUES IN ADDICTION
    34 Nonmedical Use, Misuse, and Abuse of Prescription Medications
    Martha J. Wunsch, MD, FAAP, FASAM
    35 Special Issues in Treatment: Women
    Joan E. Zweben, PhD
    SIDEBAR: Military Sexual Trauma
    Joan E. Zweben, PhD
    36 Treatment of Older Adults
    Frederic C. Blow, PhD and Kristen L. Barry, PhD
    37 Cultural Issues in Addiction Medicine
    Joseph J. Westermeyer, MD, MPH, PhD
    38 College Student Drinking
    Melodie Isgro, MD
    39 Pathologic Gambling: Clinical Characteristics and Treatment
    Jon E. Grant, MD, JD, MPH, Brian L. Odlaug, MPH
    40 Sexual Addiction
    Steven J. Shoptaw, PhD and Matthew Brensilver, PhD
    41 Physician Health Programs and Addiction among Physicians
    Jeffrey Selzer, MD, FASAM
     
    SECTION 6 MANAGEMENT OF INTOXICATION AND WITHDRAWAL
    42 Management of Intoxication and Withdrawal: General Principles
    Tara M. Wright, MD, Jeffrey S. Cluver, MD, and Hugh Myrick, MD
    43 Management of Alcohol Intoxication and Withdrawal
    Alan A. Wartenberg, MD, FACP, FASAM
    44 Management of Sedative–Hypnotic Intoxication and Withdrawal
    Joseph Samuel Insler, MD
    45 Management of Opioid Intoxication and Withdrawal
    Aykut Ozden, MD
    46 Management of Stimulant, Hallucinogen, Marijuana, Phencyclidine, and Club Drug Intoxication and Withdrawal
    Jeffery N. Wilkins, MD, FASAM, DFAPA, Itai Danovitch, MD, MBA, and David A. Gorelick, MD, PhD
     
    SECTION 7 PHARMACOLOGIC INTERVENTIONS
    47 Medications for Use in Alcohol Rehabilitation
    Daniel Eckroth, MD
    48 Pharmacologic Intervention for Sedative–Hypnotic Addiction
    Jeffrey S. Cluver, MD, Tara M. Wright, MD, and Hugh Myrick, MD
    49 Pharmacologic Interventions for Opioid Dependence
    Xiaofan Li, MD, PhD, Daryl Shorter, MD, Susan M. Stine, MD, PhD, and Thomas R. Kosten, MD, PhD
    50 Opioid Maintenance Treatment
    Claudie H. Jimenez, MD, MS
    51 Special Issues in Office-Based Opioid Treatment
    Andrew J. Saxon, MD
    52 Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction
    David A. Gorelick, MD, PhD
    53 Pharmacologic Interventions for Tobacco Dependence
    Robbie Bahl, MD and Abigail J. Herron, DO
    54 Pharmacologic Interventions for Other Drug and Multiple Drug Addictions
    Jeffery N. Wilkins, MD, FASAM, DFAPA, Mark Hrymoc, MD, and David A. Gorelick, MD, PhD
     
    SECTION 8 BEHAVIORAL INTERVENTIONS
    55 Enhancing Motivation to Change
    Mirela Feurdean, MD, FACP
    56 Group Therapies
    Dennis C. Daley, PhD, Antoine Douaihy, MD, Roger D. Weiss, MD, and Delinda E. Mercer, PhD
    57 Individual Treatment
    Deborah L. Haller, PhD and Edward V. Nunes, MD
    58 Contingency Management and the Community Reinforcement Approach
    Stephen T. Higgins, PhD, Ryan Redner, PhD, and Thomas J. White, PhD
    59 Behavioral Interventions in Smoking Cessation
    Erika Litvin Bloom, PhD, Christopher W. Kahler, PhD, Adam M. Leventhal, PhD, and Richard A. Brown, PhD
    60 Network Therapy
    Dmitry Ostrovsky, MD
    61 Therapeutic Communities
    Joseph Ruggiero, PhD
    SIDEBAR: Overview of Therapeutic Community Outcome Research
    Stanley Sacks, PhD
    SIDEBAR: Modified Therapeutic Community for Persons with Co-Occurring Mental and Substance Use Disorders
    Stanley Sacks, PhD
    62 Aversion Therapies
    P. Joseph Frawley, MD and Matthew Owen Howard, MD
    63 Family Involvement in Addiction, Treatment, and Recovery
    Kathleen A. Gross, MD, Michael R. Liepman, MD, DFAPA, FASAM, Maritza M. Lagos, MD, DABAM, Belal Hegazy, MD, Chris Karampahtsis, MD, MPH, Priya Mahajan, MD
    64 Twelve-Step Facilitation Approaches
    David Dayan-Rosenman, MD, MA, MSc
    65 Microprocessor Abuse and Internet Addiction
    Richard N. Rosenthal, MD
    66 Relapse Prevention: Clinical Models and Intervention Strategies
    Antoine Douaihy, MD, Dennis C. Daley, PhD, G. Alan Marlatt, PhD, and Dennis M. Donovan, PhD
    67 Medical Management Techniques and Collaborative Care: Integrating Behavioral with Pharmacologic Interventions in Addiction Treatment
    Richard N. Rosenthal, MD
    68 Conceptual and Treatment Issues in “Behavioral Addictions”
    Abigail J. Herron, DO, Paul Rinaldi, PhD, and Petros Levounis, MD, MA
     
    SECTION 9 MUTUAL HELP, TWELVE STEP, AND OTHER RECOVERY PROGRAMS
    69 Twelve-Step Programs in Addiction Recovery
    Edgar P. Nace, MD
    70 Recent Research into Twelve-Step Programs
    Atika Zubera, MD and Petros Levounis, MD, MA, FASAM
    71 Spirituality in the Recovery Process
    Marc Galanter, MD and Sonya Lazarevic, MD
     
    SECTION 10 MEDICAL DISORDERS AND COMPLICATIONS OF ADDICTION
    72 Medical and Surgical Complications of Addiction
    Karsten Lunze, MD, MPH, DrPH, FAAP
    73 Cardiovascular Consequences of Alcohol and Other Drug Use
    Shaojie Han, MD, MS and Rashi Aggarwal, MD
    74 Liver Disorders Related to Alcohol and Other Drug Use
    Sara E. Mgaieth, MBBS, FRACP, Robert G. Batey, MD, FRACP, FRCP(UK), FAChAM, and Paul S. Haber, MD, FRACP, FAChAM
    75 Renal and Metabolic Disorders Related to Alcohol and Other Drug Use
    Susana Sanchez, MD and Erin Zerbo, MD
    76 Gastrointestinal Disorders Related to Alcohol and Other Drug Use
    Guang Chen, MBBS and Paul S. Haber, MD, FRACP, FAChAM
    77 Respiratory Tract Disorders Related to Alcohol and Other Drug Use
    Timothy Koehler Brennan, MD, MPH
    78 Neurologic Disorders Related to Alcohol and Other Drug Use
    Jason J. Sico, MD
    79 Human Immunodeficiency Virus, Tuberculosis, and Other Infectious Diseases Related to Alcohol and Other Drug Use
    Carol A. Sulis, MD
    80 Sleep Disorders Related to Alcohol and Other Drug Use
    Sanford Auerbach, MD
    81 Traumatic Injuries Related to Alcohol and Other Drug Use: Epidemiology, Screening, and Prevention
    Stephen Van Ooteghem, MD, MSW, Gail D’Onofrio, MD, MS, and Federico E. Vaca, MD, MPH
    82 Endocrine and Reproductive Disorders Related to Alcohol and Other Drug Use
    Nicole Guanci, MD and Rashi Aggarwal, MD
    83 Alcohol and Other Drug Use during Pregnancy: Management of the Mother and Child
    Michael F. Weaver, MD, FASAM, Hendrée E. Jones, PhD, and Martha J. Wunsch, MD, FAAP, FASAM
    84 Surgical Interventions in the Alcohol- or Drug-Using Patient
    Daniel P. Alford, MD, MPH, FACP, FASAM
     
    SECTION 11 CO-OCCURRING ADDICTION AND PSYCHIATRIC DISORDERS
    85 Substance-Induced Mental Disorders
    Christine Yuodelis-Flores, MD, R. Jeffrey Goldsmith, MD, and Richard K. Ries, MD, FAPA, FASAM
    86 Co-Occurring Addictive and Mood Disorders
    Edward V. Nunes, MD, Roger D. Weiss, MD, and Carrie A. Davies
    87 Co-Occurring Addiction and Anxiety Disorders
    Karen J. Hartwell, MDand Kathleen T. Brady, MD, PhD
    88 Co-Occurring Addiction and Psychotic Disorders
    Douglas Ziedonis, MD, MPH, Xiaoduo Fan, MD, MPH, MS, Aurelia N. Bizamcer, MD, PhD, Stephen A. Wyatt, DO, Makenzie E. Tonelli, BA, and David A. Smelson, PsyD
    89 Co-Occurring Addictive Disorder and Attention Deficit Hyperactivity Disorder
    Frances Rudnick Levin, MD and John J. Mariani, MD
    90 Co-Occurring Personality Disorders and Addiction
    Stephen Ross, MD
    91 Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity
    Colette L. Haward, MD
    92 Co-Occurring Addiction and Eating Disorders
    Lisa J. Merlo, PhD, MPE and Mark S. Gold, MD, FASAM
     
    SECTION 12 PAIN AND ADDICTION
    93 The Pathophysiology of Chronic Pain and Clinical Interfaces with Addiction
    Mahreen Raza, MD and Petros Levounis, MD, MA
    94 Psychological Issues in the Management of Pain
    Sean Sullivan, DO and Mirela Fuerdean, MD, FACP
    95 Rehabilitation Approaches to Pain Management
    Steven Stanos, DO and Randy L. Calisoff, MD
    96 Nonopioid Pharmacotherapy of Pain
    James A.D. Otis, MD, Michael Perloff, MD, and Gina Deck, MD
    97 Opioid Therapy of Pain
    Shaojie Han, MS, MD and Petros Levounis, MD, MA, FASAM
    98 Comorbid Pain and Addiction
    Noam Koenigsberg, MD
    99 Legal and Regulatory Considerations in Opioid Prescribing
    David J. Copenhaver, MD MPH, Wesley Prickett, MD, and Scott M. Fishman, MD
     
    SECTION 13 CHILDREN AND ADOLESCENTS
    100 Epidemiology of Adolescent Substance Use
    Kirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH
    SIDEBAR: Adolescents’ Attitudes toward Alcohol and Other Drugs
    Kirstin A.M. Nackers, MD, Melissa Weddle, MD, MPH, and Patricia K. Kokotailo, MD, MPH
    SIDEBAR: Medical Marijuana Policy and Youth
    Sion K. Harris, PhD, CPH, Julie K. Johnson, MA, and John R. Knight, MD
    101 Preventing Substance Use among Children and Adolescents
    Kenneth W. Griffin, PhD, MPH and Gilbert J. Botvin, PhD
    102 Neurobiology of Addiction from a Developmental Perspective
    Deborah R. Simkin, MD
    103 Screening and Brief Intervention for Adolescents
    Traci L. Brooks, MD and John R. Knight, MD
    104 Assessing Adolescent Substance Use
    Ken C. Winters, PhD, Tamara Fahnhorst, MPH, Andria Botzet, MA, Ali Nicholson, BS, Randy Stinchfield, PhD, and Walker Krepps, BA
    105 Placement Criteria and Strategies for Adolescent Treatment Matching
    Marc Fishman, MD
    SIDEBAR: Confidentiality in Dealing with Adolescents
    Margaret R. Moon, MD, MPH
    SIDEBAR: Drug Testing Adolescents in School
    J. Wesley Boyd, MD, PhD
    106 Adolescent Treatment and Relapse Prevention
    Steven L. Jaffe, MD, Ashraf Attalla, MD, and Diana I. Simeonova, Dipl-Psych, PhD
    107 Pharmacotherapy for Adolescents with Substance Use Disorders
    Geetha A. Subramaniam, MD, FAPA and Lisa A. Marsch, PhD
    108 Co-Occurring Psychiatric Disorders in Adolescents
    Ramon Solhkhah, MD and Muhammad Abbas, MD
     
    SECTION 14 ETHICAL, LEGAL, AND LIABILITY ISSUES IN ADDICTION PRACTICE
    109 Ethical Issues in Addiction Practice
    Timothy Koehler Brennan, MD, MPH
    110 Consent and Confidentiality Issues in Addiction Practice
    R. Corey Waller, MD, MS, FACEP, ABAM
    111 Clinical, Ethical, and Legal Considerations in Prescribing Drugs with Abuse Potential
    Andrew O’Hagan, MD
    SIDEBAR: Drug Control Policy: History and Future Directions
    Robert L. DuPont, MD, FASAM and John J. Coleman, PhD
    112 The Science and Clinical Uses of Drug Testing
    Robert L. DuPont, MD, FASAM, Bruce A. Goldberger, PhD, DABFT, and Mark S. Gold, MD, FASAM
    SIDEBAR: Workplace Drug Testing and the Role of the Medical Review Officer
    Robert L. Dupont, MD, FASAM and James L. Ferguson, DO, FASAM
    113 Drug Treatment Courts and the Treatment of Persons in the Criminal Justice System
    The Hon. Peggy Fulton Hora, JD (Ret.)
    SIDEBAR: Therapeutic Jurisprudence
    Daniel Pulcherio Fensterseifer
    SIDEBAR: Treatment of Individuals in the Criminal Justice Population
    Lori D. Karan, MD, FACP, FASAM and Randall T. Brown, MD, PhD, FASAM
    114 Preventing and Treating Substance Use Disorders in Military Personnel
    Saadiq J. Bey, MSW, CASAC, ICADC
    SIDEBAR: Risk Factors for Military Families
    Joan E. Zweben, PhD and Susan Storti, PhD, RN, CARN-AP
     
    Index
  • Review
9781451194463 The ASAM Essentials of Addiction Medicine 9781451194463 Home / Medicine / The ASAM Essentials of Addiction Medicine 1 https://shop.lww.com/the-asam-essentials-of-addiction-medicine/p/9781451194463 //cdn-tp2.mozu.com/16833-25855/cms/25855/files/c787e8f1-92ac-4a2e-8896-e6412e4eb3dc 92.99 92.99 1

Your cart cannot contain products from multiple regions.
If you click continue, items in the cart from the previous region will be removed. To keep items from the previous region in your cart, click cancel.

This item is not related to current region.